Cargando…
Brief Consent Methods Enable Rapid Enrollment in Acute Stroke Trial: Results From the TICH-2 Randomized Controlled Trial
BACKGROUND: Seeking consent rapidly in acute stroke trials is crucial as interventions are time sensitive. We explored the association between consent pathways and time to enrollment in the TICH-2 (Tranexamic Acid in Intracerebral Haemorrhage-2) randomized controlled trial. METHODS: Consent was prov...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7612544/ https://www.ncbi.nlm.nih.gov/pubmed/34847710 http://dx.doi.org/10.1161/STROKEAHA.121.035191 |
_version_ | 1783605380688904192 |
---|---|
author | Law, Zhe Kang Appleton, Jason P. Scutt, Polly Roberts, Ian Al-Shahi Salman, Rustam England, Timothy J. Werring, David J. Robinson, Thompson Krishnan, Kailash Dineen, Robert A. Laska, Ann Charlotte Lyrer, Philippe A. Egea-Guerrero, Juan Jose Karlinski, Michal Christensen, Hanne Roffe, Christine Bereczki, Daniel Ozturk, Serefnur Thanabalan, Jegan Collins, Ronan Beridze, Maia Ciccone, Alfonso Duley, Lelia Shone, Angela Bath, Philip M. Sprigg, Nikola |
author_facet | Law, Zhe Kang Appleton, Jason P. Scutt, Polly Roberts, Ian Al-Shahi Salman, Rustam England, Timothy J. Werring, David J. Robinson, Thompson Krishnan, Kailash Dineen, Robert A. Laska, Ann Charlotte Lyrer, Philippe A. Egea-Guerrero, Juan Jose Karlinski, Michal Christensen, Hanne Roffe, Christine Bereczki, Daniel Ozturk, Serefnur Thanabalan, Jegan Collins, Ronan Beridze, Maia Ciccone, Alfonso Duley, Lelia Shone, Angela Bath, Philip M. Sprigg, Nikola |
author_sort | Law, Zhe Kang |
collection | PubMed |
description | BACKGROUND: Seeking consent rapidly in acute stroke trials is crucial as interventions are time sensitive. We explored the association between consent pathways and time to enrollment in the TICH-2 (Tranexamic Acid in Intracerebral Haemorrhage-2) randomized controlled trial. METHODS: Consent was provided by patients or by a relative or an independent doctor in incapacitated patients, using a 1-stage (full written consent) or 2-stage (initial brief consent followed by full written consent post-randomization) approach. The computed tomography-to-randomization time according to consent pathways was compared using the Kruskal-Wallis test. Multivariable logistic regression was performed to identify variables associated with onset-to-randomization time of ≤3 hours. RESULTS: Of 2325 patients, 817 (35%) gave self-consent using 1-stage (557; 68%) or 2-stage consent (260; 32%). For 1507 (65%), consent was provided by a relative (1 stage, 996 [66%]; 2 stage, 323 [21%]) or a doctor (all 2-stage, 188 [12%]). One patient did not record prerandomization consent, with written consent obtained subsequently. The median (interquartile range) computed tomography-to-randomization time was 55 (38–93) minutes for doctor consent, 55 (37–95) minutes for 2-stage patient, 69 (43–110) minutes for 2-stage relative, 75 (48–124) minutes for 1-stage patient, and 90 (56–155) minutes for 1-stage relative consents (P<0.001). Two-stage consent was associated with onset-to-randomization time of ≤3 hours compared with 1-stage consent (adjusted odds ratio, 1.9 [95% CI, 1.5–2.4]). Doctor consent increased the odds (adjusted odds ratio, 2.3 [1.5–3.5]) while relative consent reduced the odds of randomization ≤3 hours (adjusted odds ratio, 0.10 [0.03–0.34]) compared with patient consent. Only 2 of 771 patients (0.3%) in the 2-stage pathways withdrew consent when full consent was sought later. Two-stage consent process did not result in higher withdrawal rates or loss to follow-up. CONCLUSIONS: The use of initial brief consent was associated with shorter times to enrollment, while maintaining good participant retention. Seeking written consent from relatives was associated with significant delays. REGISTRATION: URL: https://www.isrctn.com; Unique identifier: ISRCTN93732214. |
format | Online Article Text |
id | pubmed-7612544 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-76125442022-04-01 Brief Consent Methods Enable Rapid Enrollment in Acute Stroke Trial: Results From the TICH-2 Randomized Controlled Trial Law, Zhe Kang Appleton, Jason P. Scutt, Polly Roberts, Ian Al-Shahi Salman, Rustam England, Timothy J. Werring, David J. Robinson, Thompson Krishnan, Kailash Dineen, Robert A. Laska, Ann Charlotte Lyrer, Philippe A. Egea-Guerrero, Juan Jose Karlinski, Michal Christensen, Hanne Roffe, Christine Bereczki, Daniel Ozturk, Serefnur Thanabalan, Jegan Collins, Ronan Beridze, Maia Ciccone, Alfonso Duley, Lelia Shone, Angela Bath, Philip M. Sprigg, Nikola Stroke Clinical Trials BACKGROUND: Seeking consent rapidly in acute stroke trials is crucial as interventions are time sensitive. We explored the association between consent pathways and time to enrollment in the TICH-2 (Tranexamic Acid in Intracerebral Haemorrhage-2) randomized controlled trial. METHODS: Consent was provided by patients or by a relative or an independent doctor in incapacitated patients, using a 1-stage (full written consent) or 2-stage (initial brief consent followed by full written consent post-randomization) approach. The computed tomography-to-randomization time according to consent pathways was compared using the Kruskal-Wallis test. Multivariable logistic regression was performed to identify variables associated with onset-to-randomization time of ≤3 hours. RESULTS: Of 2325 patients, 817 (35%) gave self-consent using 1-stage (557; 68%) or 2-stage consent (260; 32%). For 1507 (65%), consent was provided by a relative (1 stage, 996 [66%]; 2 stage, 323 [21%]) or a doctor (all 2-stage, 188 [12%]). One patient did not record prerandomization consent, with written consent obtained subsequently. The median (interquartile range) computed tomography-to-randomization time was 55 (38–93) minutes for doctor consent, 55 (37–95) minutes for 2-stage patient, 69 (43–110) minutes for 2-stage relative, 75 (48–124) minutes for 1-stage patient, and 90 (56–155) minutes for 1-stage relative consents (P<0.001). Two-stage consent was associated with onset-to-randomization time of ≤3 hours compared with 1-stage consent (adjusted odds ratio, 1.9 [95% CI, 1.5–2.4]). Doctor consent increased the odds (adjusted odds ratio, 2.3 [1.5–3.5]) while relative consent reduced the odds of randomization ≤3 hours (adjusted odds ratio, 0.10 [0.03–0.34]) compared with patient consent. Only 2 of 771 patients (0.3%) in the 2-stage pathways withdrew consent when full consent was sought later. Two-stage consent process did not result in higher withdrawal rates or loss to follow-up. CONCLUSIONS: The use of initial brief consent was associated with shorter times to enrollment, while maintaining good participant retention. Seeking written consent from relatives was associated with significant delays. REGISTRATION: URL: https://www.isrctn.com; Unique identifier: ISRCTN93732214. Lippincott Williams & Wilkins 2021-12-01 2022-04 /pmc/articles/PMC7612544/ /pubmed/34847710 http://dx.doi.org/10.1161/STROKEAHA.121.035191 Text en © 2021 The Authors. https://creativecommons.org/licenses/by/4.0/Stroke is published on behalf of the American Heart Association, Inc., by Wolters Kluwer Health, Inc. This is an open access article under the terms of the Creative Commons Attribution (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution, and reproduction in any medium, provided that the original work is properly cited. |
spellingShingle | Clinical Trials Law, Zhe Kang Appleton, Jason P. Scutt, Polly Roberts, Ian Al-Shahi Salman, Rustam England, Timothy J. Werring, David J. Robinson, Thompson Krishnan, Kailash Dineen, Robert A. Laska, Ann Charlotte Lyrer, Philippe A. Egea-Guerrero, Juan Jose Karlinski, Michal Christensen, Hanne Roffe, Christine Bereczki, Daniel Ozturk, Serefnur Thanabalan, Jegan Collins, Ronan Beridze, Maia Ciccone, Alfonso Duley, Lelia Shone, Angela Bath, Philip M. Sprigg, Nikola Brief Consent Methods Enable Rapid Enrollment in Acute Stroke Trial: Results From the TICH-2 Randomized Controlled Trial |
title | Brief Consent Methods Enable Rapid Enrollment in Acute Stroke Trial: Results From the TICH-2 Randomized Controlled Trial |
title_full | Brief Consent Methods Enable Rapid Enrollment in Acute Stroke Trial: Results From the TICH-2 Randomized Controlled Trial |
title_fullStr | Brief Consent Methods Enable Rapid Enrollment in Acute Stroke Trial: Results From the TICH-2 Randomized Controlled Trial |
title_full_unstemmed | Brief Consent Methods Enable Rapid Enrollment in Acute Stroke Trial: Results From the TICH-2 Randomized Controlled Trial |
title_short | Brief Consent Methods Enable Rapid Enrollment in Acute Stroke Trial: Results From the TICH-2 Randomized Controlled Trial |
title_sort | brief consent methods enable rapid enrollment in acute stroke trial: results from the tich-2 randomized controlled trial |
topic | Clinical Trials |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7612544/ https://www.ncbi.nlm.nih.gov/pubmed/34847710 http://dx.doi.org/10.1161/STROKEAHA.121.035191 |
work_keys_str_mv | AT lawzhekang briefconsentmethodsenablerapidenrollmentinacutestroketrialresultsfromthetich2randomizedcontrolledtrial AT appletonjasonp briefconsentmethodsenablerapidenrollmentinacutestroketrialresultsfromthetich2randomizedcontrolledtrial AT scuttpolly briefconsentmethodsenablerapidenrollmentinacutestroketrialresultsfromthetich2randomizedcontrolledtrial AT robertsian briefconsentmethodsenablerapidenrollmentinacutestroketrialresultsfromthetich2randomizedcontrolledtrial AT alshahisalmanrustam briefconsentmethodsenablerapidenrollmentinacutestroketrialresultsfromthetich2randomizedcontrolledtrial AT englandtimothyj briefconsentmethodsenablerapidenrollmentinacutestroketrialresultsfromthetich2randomizedcontrolledtrial AT werringdavidj briefconsentmethodsenablerapidenrollmentinacutestroketrialresultsfromthetich2randomizedcontrolledtrial AT robinsonthompson briefconsentmethodsenablerapidenrollmentinacutestroketrialresultsfromthetich2randomizedcontrolledtrial AT krishnankailash briefconsentmethodsenablerapidenrollmentinacutestroketrialresultsfromthetich2randomizedcontrolledtrial AT dineenroberta briefconsentmethodsenablerapidenrollmentinacutestroketrialresultsfromthetich2randomizedcontrolledtrial AT laskaanncharlotte briefconsentmethodsenablerapidenrollmentinacutestroketrialresultsfromthetich2randomizedcontrolledtrial AT lyrerphilippea briefconsentmethodsenablerapidenrollmentinacutestroketrialresultsfromthetich2randomizedcontrolledtrial AT egeaguerrerojuanjose briefconsentmethodsenablerapidenrollmentinacutestroketrialresultsfromthetich2randomizedcontrolledtrial AT karlinskimichal briefconsentmethodsenablerapidenrollmentinacutestroketrialresultsfromthetich2randomizedcontrolledtrial AT christensenhanne briefconsentmethodsenablerapidenrollmentinacutestroketrialresultsfromthetich2randomizedcontrolledtrial AT roffechristine briefconsentmethodsenablerapidenrollmentinacutestroketrialresultsfromthetich2randomizedcontrolledtrial AT bereczkidaniel briefconsentmethodsenablerapidenrollmentinacutestroketrialresultsfromthetich2randomizedcontrolledtrial AT ozturkserefnur briefconsentmethodsenablerapidenrollmentinacutestroketrialresultsfromthetich2randomizedcontrolledtrial AT thanabalanjegan briefconsentmethodsenablerapidenrollmentinacutestroketrialresultsfromthetich2randomizedcontrolledtrial AT collinsronan briefconsentmethodsenablerapidenrollmentinacutestroketrialresultsfromthetich2randomizedcontrolledtrial AT beridzemaia briefconsentmethodsenablerapidenrollmentinacutestroketrialresultsfromthetich2randomizedcontrolledtrial AT cicconealfonso briefconsentmethodsenablerapidenrollmentinacutestroketrialresultsfromthetich2randomizedcontrolledtrial AT duleylelia briefconsentmethodsenablerapidenrollmentinacutestroketrialresultsfromthetich2randomizedcontrolledtrial AT shoneangela briefconsentmethodsenablerapidenrollmentinacutestroketrialresultsfromthetich2randomizedcontrolledtrial AT bathphilipm briefconsentmethodsenablerapidenrollmentinacutestroketrialresultsfromthetich2randomizedcontrolledtrial AT spriggnikola briefconsentmethodsenablerapidenrollmentinacutestroketrialresultsfromthetich2randomizedcontrolledtrial |